Literature DB >> 21917685

Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia.

Suzanne M Koopmans1, Freek J Bot, King H Lam, Arienne M W van Marion, Hendrik de Raeve, Konnie M Hebeda.   

Abstract

Early phases of polycythemia vera, essential thrombocythemia, and primary myelofibrosis (PMF) can be difficult to distinguish by morphologic studies alone because they share many morphologic characteristics. Histologic criteria according to the 2008 World Health Organization (WHO) classification are part of the myeloproliferative neoplasia (MPN) diagnosis. Our aim was to assess the reproducibility of morphologic characteristics and determine their relative importance for histologic diagnoses on selected trephine biopsy sections. For the study, 56 prefibrotic MPN trephine specimens were blindly reviewed by 4 hematopathologists using a scoring list of 16 histologic characteristics mentioned in the WHO classification. Consensus was defined as agreement by 3 of 4 hematopathologists. High degrees of consensus were reached for individual major morphologic features used in the WHO classification, especially for the nuclear features of megakaryocytes (83%). Some of the features correlated positively or negatively with the histologic diagnosis of PMF. Consensus for the histologic classification of MPN was reached in 39 (70%) of 56 cases without knowledge of clinical data. This finding indicates a difference in the relative importance assigned to individual histologic characteristics by different hematopathologists.

Entities:  

Mesh:

Year:  2011        PMID: 21917685     DOI: 10.1309/AJCP2UG9SGGWAHUA

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.

Authors:  Giovanni Barosi; Vittorio Rosti; Elisa Bonetti; Rita Campanelli; Adriana Carolei; Paolo Catarsi; Antonina M Isgrò; Letizia Lupo; Margherita Massa; Valentina Poletto; Gianluca Viarengo; Laura Villani; Umberto Magrini
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

2.  Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm.

Authors:  Shuchi Ghai; Sharada Rai
Journal:  South Asian J Cancer       Date:  2017 Apr-Jun

3.  Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.

Authors:  Elisa Rumi; Emanuela Boveri; Marta Bellini; Daniela Pietra; Virginia V Ferretti; Emanuela Sant'Antonio; Chiara Cavalloni; Ilaria C Casetti; Elisa Roncoroni; Michele Ciboddo; Pietro Benvenuti; Benedetta Landini; Elena Fugazza; Daniela Troletti; Cesare Astori; Mario Cazzola
Journal:  Oncotarget       Date:  2017-10-06

Review 4.  Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-08-14       Impact factor: 11.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.